Imugene Limited's total liabilities is $14M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Imugene Limited (IUGNF) currently reports a total liabilities of $14M as of June 2026. That compares with $39M in the prior-year period — down 63.7% year over year. Use the charts on this page to explore Imugene Limited's total liabilities history and peer comparisons.
Imugene Limited's total liabilities decreased from $39M to $14M — a 63.7% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Imugene Limited reported $14M in total liabilities as of June 2026. That compares with $39M in the prior-year period — down 63.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current total liabilities of $14M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Imugene Limited, and consider following IUGNF for alerts when major investors trade the stock.
Imugene Limited is classified in the Healthcare sector. On total liabilities, it currently shows $14M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing IUGNF with unrelated industries.